After rollout under emergency authorisation, manufacturers of covid-19 vaccines now have their sights on regulatory approval. But what’s the rush, asks Peter Doshi, and is just six months of data from now unblinded trials acceptable?http://ow.ly/at2D50F2Mqn
-
-
Arnold Ventures, who fund his salary at University of Maryland Baltimore, just happen to donate lots of money to BMJ.
-
Very interesting…
- Show replies
New conversation -
-
-
Thanks! Great timing, haha
-
Pro tip: Search
@ScienceBasedMed and@oracknows blogs before asking.
End of conversation
New conversation -
-
-
How in the world is he a drug safety expert and also wrote that nonsense article about "suspected covid-19" that required no expertise to know was totally wrong?
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.